Get started
Author

Ricardo Eccard da Silva

Observed names: RICARDO ECCARD DA SILVA, Ricardo Eccard SILVA, Silva, Ricardo Eccard da, da Silva, Ricardo Eccard
ORCID: 0000-0003-2322-7163
Observed ORCID: 0000-0003-2322-7163
OpenAlex ID: A5002862224
Globalization of clinical trials: ethical and regulatory implications
2016 · Ricardo Eccard da Silva, Angélica Amorim Amato, et al. · International Journal of Clinical Trials · 39
PDF
Post-marketing authorisation safety and efficacy surveillance of advanced therapy medicinal products in Brazil, the European Union, the United States and Japan
2023 · Kelly Lucy Guimarães Gomes, Ricardo Eccard da Silva, et al. · Cytotherapy · 28
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics
2023 · Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, et al. · Globalization and Health · 13
PDF
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis
2024 · Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, et al. · BMC Public Health · 12
Comparison of new Brazilian legislation for the approval of advanced therapy medicinal products with existing systems in the USA, European Union and Japan
2022 · Kelly Lucy Guimarães Gomes, Ricardo Eccard da Silva, et al. · Cytotherapy · 12
The High “Cost” of Experimental Drugs Obtained Through Health Litigation in Brazil
2020 · Ricardo Eccard da Silva, Elisangela da Costa Lima, et al. · Frontiers in Pharmacology · 11
PDF
The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends
2018 · Ricardo Eccard da Silva, Angélica Amorim Amato, et al. · European Journal of Clinical Pharmacology · 11
Trends in research involving human beings in Brazil.
2015 · Ricardo Eccard da Silva, Maria Rita Carvalho Novaes, et al. · PubMed · 9
Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries
2018 · Ricardo Eccard da Silva, Angélica Amorim Amato, et al. · Journal of Oncology · 5
PDF
Incentivos e desafios relacionados à condução da pesquisa científica, tecnológica e de inovação no âmbito do Sistema Único de Saúde no Distrito Federal, Brasil
2019 · Maria Rita Carvalho Garbi Novaes, Marcia Luz da Motta, et al. · Ciência & Saúde Coletiva · 4
PDF
Desafios na condução de pesquisas sobre a COVID-19 envolvendo seres humanos no Brasil
2020 · ita Carvalho Gabi Novaes, Ricardo Eccard da Silva, et al. · Comunicação em Ciências da Saúde · 3
Funding of clinical trials in Brazil for the development of new drugs: who are the sponsors?
2015 · Ricardo Eccard da Silva, Angélica Amorim Amato, et al. · International Journal of Clinical Trials · 3
PDF
Pharmaceutical innovation and technological dependence: a study of the Brazilian scenario
2016 · Ricardo Eccard da Silva, Angélica Amorim Amato, et al. · International Journal of Clinical Trials · 2
PDF
Políticas públicas para doenças raras no Brasil: Caminho Regulatório, Desafios na Pesquisa e Acesso a Medicamentos órfãos
2025 · Fábio Oliveira AQUINO, Ricardo Eccard SILVA, et al. · Journal of Hospital Pharmacy and Health Services · 1
PDF
Rare diseases, trends and challenges for scientific advances: a snapshot of a decade of research in Brazil
2024 · Fábio de Oliveira Aquino, Ricardo Eccard da Silva, et al. · Concilium · 1
Association between disasters, damage and destruction of health facilities and public spending in Brazil
2026 · RICARDO ECCARD DA SILVA, MARIA RITA C.G. NOVAES, et al. · Anais da Academia Brasileira de Ciências
PDF
Works count: 26
Citation count: 154
H-index: 8
I10-index: 7
Year
Topic
Type